FDA Adds Optic Neuropathy Warning to GLP-1 RA Drug Labels
A causal relationship between GLP-1 RAs and "eye stroke" remains tenuous, but the FDA’s decision seems reasonable The post FDA Adds Optic Neuropathy Warning to GLP-1 RA Drug Labels first appeared on Science-Based Medicine .
We haven't written up this one. Science-Based Medicine has the full story — the link below goes straight to it.